Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Profound Medical Corp
T.PRN
Alternate Symbol(s):
PROF
Healthcare
Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed...
to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:PRN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Mar 30, 2021 3:48pm
RE:Price Decline
Ya - just seems like a normal pull-back (as we've seen a few times before. We have new locations (10 in the USA now). GUD just reiterated the sale of the shares but they announced it a few
...more
(6023)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 28, 2021 8:17am
Price Decline
For anyone wondering about the significant decline in the SP this week, there was no company news and as you know, Raymond James reaffirmed their $43 target. The only thing I can find is that in their
...more
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 23, 2021 10:32am
Welcome ...
Welcome to Stanford Medical - Cancer Center That makes it 10 locations across the USA ... 2 of which are learning sites (UCLA and John Hopkins).
(26)
•••
danche
X
View Profile
View Bullboard History
Post by
danche
on Mar 10, 2021 12:15pm
Raymond James Strong Buy $34.00 USD
EOM
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 10, 2021 9:36am
Taking a closer look at RadNet ...
Looking at the US map and picking out the large cities that need a TULSA-PRO, brings one thing to light ... A company like RadNet can really fill in the gaps, if they want to. Obviously we'
...more
(6023)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 09, 2021 8:22am
TSX SmallCap Index
Small caps have been on a tear, outperforming large caps by a significant margin. In 2020, the S&P/TSX SmallCap Index climbed 10 per cent, 12.9 per cent including dividends, while the S
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 08, 2021 2:15pm
Confirmed at Children's Hospital D.C.
Sorry if you already know this. I'm just paying closer attention to Sonalleve now - been more focused on TULSA-PRO https://profoundmedical.com/interview-with-dr-sharma/
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 08, 2021 9:03am
A little more on Children's Hospital in D.C.
Following the site’s designation as a Center of Excellence, the team plans to further explore oncological applications of focused ultrasound, particularly to augment chemotherapy and immunotherapy for
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 07, 2021 9:32pm
Sonalleve
3 Guest Speakers for Sonalleve webinar in May ... 2 from Children's National Hospital in Washington DC and 1 professor from Switzerland. Maybe CNH in DC is already working with the Sonalleve
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 05, 2021 6:25pm
UCLA ...
As quickly as it appeared on the list, it disappeared. You will now notice that UCLU is back on the USA map. Not sure what happened but ... we're back on there. 2021 is coming together nicely w.r
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 05, 2021 9:11am
webcasts ...
keep in mind ... there are good little tid-bits in the last two webcasts on PRN's website. I think it's Cowen and Raymond James. EOM
(6023)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 03, 2021 10:54am
Revised Targets
Cowen and Co. analyst Joshua Jennings raised his target for Mississauga-based Profound Medical Corp. to US$28 from US$22 with an “outperform” rating, while Jefferies’ Raj Denhoy cut
...more
(58)
•••
snootchybootchy
X
View Profile
View Bullboard History
Post by
snootchybootchy
on Mar 02, 2021 4:19pm
Year-End Results
Well, now we know why the share price has been dropping. Still, 60% share price appreciation over the past 52 weeks is pretty good and the future remains bright. I'm hoping the share price will be
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Feb 28, 2021 5:00pm
RE:Time for press release? Dec 21 & Jan 5, 21 were uber good
I think shareholders (and new shareholders) need to see growth - need to see developments. Profound reports on March 2. Profound speaks at Raymond James on March 3. Profound speaks at Cowan on March
...more
(27)
•••
BuenaSuertaAtod
X
View Profile
View Bullboard History
Post by
BuenaSuertaAtod
on Feb 26, 2021 6:57am
Time for press release? Dec 21 & Jan 5, 21 were uber good
for the SP. Now it's languishing with no news since Jan 5. Is a press release all we need?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil